• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对无数奥密克戎亚变体的深度结构分析揭示了疫苗逃逸免疫的热点。

Deep Structural Analysis of Myriads of Omicron Sub-Variants Revealed Hotspot for Vaccine Escape Immunity.

作者信息

Gerardi Valeria, Rohaim Mohammed A, Naggar Rania F El, Atasoy Mustafa O, Munir Muhammad

机构信息

Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YG, UK.

Department of Virology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt.

出版信息

Vaccines (Basel). 2023 Mar 15;11(3):668. doi: 10.3390/vaccines11030668.

DOI:10.3390/vaccines11030668
PMID:36992252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10059128/
Abstract

The emergence of the Omicron variant has reinforced the importance of continued SARS-CoV-2 evolution and its possible impact on vaccine effectiveness. Specifically, mutations in the receptor-binding domain (RBD) are critical to comprehend the flexibility and dynamicity of the viral interaction with the human agniotensin-converting enzyme 2 (hACE2) receptor. To this end, we have applied a string of deep structural and genetic analysis tools to map the substitution patterns in the S protein of major Omicron sub-variants (n = 51) with a primary focus on the RBD mutations. This head-to-head comparison of Omicron sub-variants revealed multiple simultaneous mutations that are attributed to antibody escape, and increased affinity and binding to hACE2. Our deep mapping of the substitution matrix indicated a high level of diversity at the N-terminal and RBD domains compared with other regions of the S protein, highlighting the importance of these two domains in a matched vaccination approach. Structural mapping identified highly variable mutations in the up confirmation of the S protein and at sites that critically define the function of the S protein in the virus pathobiology. These substitutional trends offer support in tracking mutations along the evolutionary trajectories of SAR-CoV-2. Collectively, the findings highlight critical areas of mutations across the major Omicron sub-variants and propose several hotspots in the S proteins of SARS-CoV-2 sub-variants to train the future design and development of COVID-19 vaccines.

摘要

奥密克戎变种的出现强化了新冠病毒持续进化的重要性及其对疫苗有效性可能产生的影响。具体而言,受体结合域(RBD)中的突变对于理解病毒与人类血管紧张素转换酶2(hACE2)受体相互作用的灵活性和动态性至关重要。为此,我们应用了一系列深入的结构和基因分析工具,以绘制主要奥密克戎子变种(n = 51)S蛋白中的替换模式,主要关注RBD突变。这种对奥密克戎子变种的直接比较揭示了多个同时发生的突变,这些突变归因于抗体逃逸,以及与hACE2的亲和力和结合力增加。我们对替换矩阵的深入绘制表明,与S蛋白的其他区域相比,N端和RBD结构域具有高度的多样性,突出了这两个结构域在匹配疫苗接种方法中的重要性。结构映射确定了S蛋白向上构象中以及在病毒病理生物学中关键定义S蛋白功能的位点处的高度可变突变。这些替换趋势为追踪新冠病毒进化轨迹中的突变提供了支持。总体而言,这些发现突出了主要奥密克戎子变种中突变的关键区域,并提出了新冠病毒子变种S蛋白中的几个热点,以指导未来新冠疫苗的设计和开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/10059128/0f732d55f0ed/vaccines-11-00668-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/10059128/b94adcff8ab8/vaccines-11-00668-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/10059128/252805b9681d/vaccines-11-00668-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/10059128/d9349a5ca5cc/vaccines-11-00668-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/10059128/67709b23b925/vaccines-11-00668-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/10059128/76e3e1f069ea/vaccines-11-00668-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/10059128/01529d10f1f7/vaccines-11-00668-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/10059128/0f732d55f0ed/vaccines-11-00668-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/10059128/b94adcff8ab8/vaccines-11-00668-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/10059128/252805b9681d/vaccines-11-00668-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/10059128/d9349a5ca5cc/vaccines-11-00668-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/10059128/67709b23b925/vaccines-11-00668-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/10059128/76e3e1f069ea/vaccines-11-00668-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/10059128/01529d10f1f7/vaccines-11-00668-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3de/10059128/0f732d55f0ed/vaccines-11-00668-g007.jpg

相似文献

1
Deep Structural Analysis of Myriads of Omicron Sub-Variants Revealed Hotspot for Vaccine Escape Immunity.对无数奥密克戎亚变体的深度结构分析揭示了疫苗逃逸免疫的热点。
Vaccines (Basel). 2023 Mar 15;11(3):668. doi: 10.3390/vaccines11030668.
2
Analyzing the interaction of human ACE2 and RBD of spike protein of SARS-CoV-2 in perspective of Omicron variant.从奥密克戎变异株角度分析人类血管紧张素转换酶2(ACE2)与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白受体结合域(RBD)的相互作用。
EXCLI J. 2022 Mar 10;21:610-620. doi: 10.17179/excli2022-4721. eCollection 2022.
3
Evolutionary progression of collective mutations in Omicron sub-lineages towards efficient RBD-hACE2: Allosteric communications between and within viral and human proteins.奥密克戎亚谱系中集体突变向高效RBD-hACE2的进化进程:病毒蛋白与人类蛋白之间及内部的别构通讯
Comput Struct Biotechnol J. 2022;20:4562-4578. doi: 10.1016/j.csbj.2022.08.015. Epub 2022 Aug 17.
4
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.一种糖基化 RBD 蛋白诱导针对奥密克戎和其他变体的增强型中和抗体,提高对 SARS-CoV-2 感染的保护作用。
J Virol. 2022 Sep 14;96(17):e0011822. doi: 10.1128/jvi.00118-22. Epub 2022 Aug 16.
5
Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment.Omicron (BA.1)及其子变体(BA.1.1、BA.2 和 BA.3)对 SARS-CoV-2 刺突的感染性和致病性:基于序列和结构的比较计算评估。
J Med Virol. 2022 Oct;94(10):4780-4791. doi: 10.1002/jmv.27927. Epub 2022 Jun 16.
6
Analysis of a SARS-CoV-2 convalescent cohort identified a common strategy for escape of vaccine-induced anti-RBD antibodies by Beta and Omicron variants.对 SARS-CoV-2 恢复期患者队列的分析表明,β和奥密克戎变异株通过共同策略逃避了疫苗诱导的针对 RBD 的抗体。
EBioMedicine. 2022 Jun;80:104025. doi: 10.1016/j.ebiom.2022.104025. Epub 2022 May 6.
7
MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular immune responses.基于 MVA 的疫苗候选物表达了武汉、β或奥密克戎 BA.1 变异株的 prefusion-稳定化 Spike 蛋白,可保护 K18-hACE2 转基因小鼠免受奥密克戎感染,并引发强烈和广泛的特异性体液和细胞免疫反应。
Front Immunol. 2024 Aug 29;15:1420304. doi: 10.3389/fimmu.2024.1420304. eCollection 2024.
8
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.一种基于三聚体 RBD 的马赛克型 COVID-19 疫苗候选物可诱导针对奥密克戎和其他 SARS-CoV-2 变体的强大中和作用。
Elife. 2022 Aug 25;11:e78633. doi: 10.7554/eLife.78633.
9
Improved Binding Affinity of Omicron's Spike Protein for the Human Angiotensin-Converting Enzyme 2 Receptor Is the Key behind Its Increased Virulence.奥密克戎刺突蛋白与人血管紧张素转化酶 2 受体结合亲和力增强是其毒力增加的关键。
Int J Mol Sci. 2022 Mar 21;23(6):3409. doi: 10.3390/ijms23063409.
10
Structural topological analysis of spike proteins of SARS-CoV-2 variants of concern highlight distinctive amino acid substitution patterns.结构拓扑分析表明,SARS-CoV-2 关注变体的刺突蛋白具有独特的氨基酸取代模式。
Eur J Cell Biol. 2022 Sep-Nov;101(4):151275. doi: 10.1016/j.ejcb.2022.151275. Epub 2022 Sep 19.

引用本文的文献

1
New Trends in SARS-CoV-2 Variants and Vaccines.新型冠状病毒变种与疫苗的新趋势
Vaccines (Basel). 2025 Mar 3;13(3):265. doi: 10.3390/vaccines13030265.
2
A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2.一种重组蛋白XBB.1.5 RBD/明矾/磷酸胞苷疫苗可引发针对新冠病毒奥密克戎亚变体的高中和抗体滴度。
Vaccines (Basel). 2023 Oct 1;11(10):1557. doi: 10.3390/vaccines11101557.
3
Evaluation of a SARS-CoV-2 spike protein ectodomain subunit vaccine with a squalene emulsion adjuvant in rodents and rhesus macaques.

本文引用的文献

1
Changes within the P681 residue of spike dictate cell fusion and syncytia formation of Delta and Omicron variants of SARS-CoV-2 with no effects on neutralization or infectivity.刺突蛋白P681残基的变化决定了新冠病毒Delta和Omicron变异株的细胞融合及多核巨细胞形成,而对中和作用或感染性无影响。
Heliyon. 2023 Jun;9(6):e16750. doi: 10.1016/j.heliyon.2023.e16750. Epub 2023 Jun 3.
2
Convergent Evolution in SARS-CoV-2 Spike Creates a Variant Soup from Which New COVID-19 Waves Emerge.SARS-CoV-2 刺突蛋白的趋同进化导致了新的 COVID-19 浪潮的变体汤的出现。
Int J Mol Sci. 2023 Jan 23;24(3):2264. doi: 10.3390/ijms24032264.
3
评估一种带有角鲨烯乳液佐剂的 SARS-CoV-2 刺突蛋白外域亚单位疫苗在啮齿动物和恒河猴中的效果。
Hum Vaccin Immunother. 2023 Aug;19(2):2258571. doi: 10.1080/21645515.2023.2258571. Epub 2023 Oct 26.
Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎XBB.1.5变体的传播性、感染性和免疫抗性增强。
Lancet Infect Dis. 2023 Mar;23(3):280-281. doi: 10.1016/S1473-3099(23)00051-8. Epub 2023 Jan 31.
4
Challenges and developments in universal vaccine design against SARS-CoV-2 variants.针对新冠病毒变异株的通用疫苗设计中的挑战与进展。
NPJ Vaccines. 2022 Dec 19;7(1):167. doi: 10.1038/s41541-022-00597-4.
5
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2.一种新型 RBD 蛋白/肽疫苗可诱导广泛中和抗体,并保护小鼠和猕猴免受 SARS-CoV-2 感染。
Emerg Microbes Infect. 2022 Dec;11(1):2724-2734. doi: 10.1080/22221751.2022.2140608.
6
Structural topological analysis of spike proteins of SARS-CoV-2 variants of concern highlight distinctive amino acid substitution patterns.结构拓扑分析表明,SARS-CoV-2 关注变体的刺突蛋白具有独特的氨基酸取代模式。
Eur J Cell Biol. 2022 Sep-Nov;101(4):151275. doi: 10.1016/j.ejcb.2022.151275. Epub 2022 Sep 19.
7
Surface charge changes in spike RBD mutations of SARS-CoV-2 and its variant strains alter the virus evasiveness HSPGs: A review and mechanistic hypothesis.刺突 RBD 突变的 SARS-CoV-2 及其变异株的表面电荷变化改变了病毒的逃避能力 HSPGs:综述和机制假说。
Front Public Health. 2022 Aug 24;10:952916. doi: 10.3389/fpubh.2022.952916. eCollection 2022.
8
SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: Are they modulating drug efficacy by altered binding strength?SARS-CoV-2 变种病毒、突变多样性和临床结果:它们是否通过改变结合强度来调节药物疗效?
Genomics. 2022 Sep;114(5):110466. doi: 10.1016/j.ygeno.2022.110466. Epub 2022 Aug 27.
9
Sub-lineages of the SARS-CoV-2 Omicron variants: Characteristics and prevention.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变种的亚谱系:特征与预防
MedComm (2020). 2022 Aug 16;3(3):e172. doi: 10.1002/mco2.172. eCollection 2022 Sep.
10
Covid-19: What we know about the BA.4 and BA.5 omicron variants.新冠病毒:我们对奥密克戎BA.4和BA.5变体的了解
BMJ. 2022 Aug 9;378:o1969. doi: 10.1136/bmj.o1969.